Kidney Friends

LONDON - Cell Medica Ltd. has treated the first patient in a Phase III trial of a cell therapy treatment for the prevention of cytomegalovirus (CMV) infection in immunocompromised bone marrow transplant patients.

Apart from assessing safety and efficacy, the 110-patient trial is intended to demonstrate that it would be possible to set up and run a commercially viable national cell therapy service.

Read the rest of this entry…

“I just never knew what it was like to really be healthy.”

At 12, Jennifer Searl (sur-hl) had a kidney transplant. From then on, she traded one health problem for another as the anti-rejection medications reeked havoc on her body.

“I had a very big problem with the kind of disfiguring growth on my legs and feet — so bad that by the time I got to college, I really couldn’t walk.”

Read the rest of this entry…